Kalif Eliyahu Sharon Insider Trades

Insider Trading History

Track insider trading activity for Kalif Eliyahu Sharon. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
Evp, Chief Financial Officer
Holding Value $5.93M 172,184 shares
Last Trade
May 14, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.46M 153,251 shares
$35.61
$34.43
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
Evp, Chief Financial Officer
Holding Value $2.06M 59,748 shares
Last Trade
Mar 05, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$633k 19,916 shares
$31.76
$34.43
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
Evp, Chief Financial Officer
Holding Value $11.2M 325,435 shares
Last Trade
Mar 05, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$633k 19,916 shares
$31.76
$34.43
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
Evp, Chief Financial Officer
Holding Value $1.6M 46,503 shares
Last Trade
Mar 04, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.87M 56,763 shares
$32.90
$34.43
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
Evp, Chief Financial Officer
Holding Value $1.83M 53,175 shares
Last Trade
Mar 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.75M 53,175 shares
$32.90
$34.43
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
Evp, Chief Financial Officer
Holding Value $10.5M 305,519 shares
Last Trade
Mar 04, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.87M 56,763 shares
$32.90
$34.43
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
Evp, Chief Financial Officer
Holding Value $1.71M 49,802 shares
Last Trade
Mar 03, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.17M 191,278 shares
$32.26
$34.43
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
Evp, Chief Financial Officer
Holding Value $8.56M 248,756 shares
Last Trade
Mar 03, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.17M 191,278 shares
$32.26
$34.43
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
Evp, Chief Financial Officer
Holding Value $1.98M 57,478 shares
Last Trade
Feb 26, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$11.6M 345,810 shares
$33.64
$34.43
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
Evp, Chief Financial Officer
Holding Value $4.87M 141,478 shares
Last Trade
Jan 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.51M 141,478 shares
$31.90
$34.43
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
Evp, Chief Financial Officer
Holding Value $13.9M 403,288 shares
Last Trade
Jun 12, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$953k 55,775 shares
$17.08
$34.43
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
Evp, Chief Financial Officer
Holding Value $2.74M 79,664 shares
Last Trade
Mar 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.27M 79,664 shares
$15.90
$34.43
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
Evp, Chief Financial Officer
Holding Value $15.8M 459,063 shares
Last Trade
Mar 05, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$340k 21,390 shares
$15.90
$34.43
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
Evp, Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Mar 05, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$340k 21,390 shares
$15.90
$34.43
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
Evp, Chief Financial Officer
Holding Value $6.81M 197,741 shares
Last Trade
Mar 03, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$797k 49,800 shares
$16.00
$34.43
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
Evp, Chief Financial Officer
Holding Value $3.43M 99,602 shares
Last Trade
Mar 03, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$797k 49,800 shares
$16.00
$34.43
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
Evp, Chief Financial Officer
Holding Value $5.09M 147,941 shares
Last Trade
Feb 28, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$904k 55,750 shares
$16.21
$34.43
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
Evp, Chief Financial Officer
Holding Value $6.31M 183,169 shares
Last Trade
Jan 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.95M 183,169 shares
$21.55
$34.43
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
Evp, Chief Financial Officer
Holding Value $7.01M 203,691 shares
Last Trade
Mar 06, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.05M 77,550 shares
$13.52
$34.43
Teva- Pharmaceutical Industries
Teva- Pharmaceutical Industries TEVA
Evp, Chief Financial Officer
Holding Value $7.15M 207,534 shares
Last Trade
Mar 04, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$450k 33,512 shares
$13.44
$34.43

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up